Delivery Order SPE2DB20D3505-SPE2DB23FU3S2
- Not listed
- This federal contract award, valued at $1,746.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUCRISA 2% ointment in 60 gram quantities, with an ultimate completion date of April 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price valued at $7,963.75, and an ultimate completion date of July 26, 2024. The award covers the procurement of EUCRISA 2% Ointment 60GM, a pharmaceutical product, to support federal healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of EUCRISA 2% ointment, a specialty pharmaceutical product, with a ceiling value of $1,554.51 and an ultimate completion date of January 14, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of EUCRISA 2% Ointment in 60-gram units under a firm fixed-price contract with a ceiling value of $4,106.07. The award was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EUCRISA 2% ointment, a topical treatment, with a ceiling value of $5,436.23 and a period of performance through January 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, valued at $2,062.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, identified as SPE2DB24D1034|SPE2DB24FVYA7, is for the delivery of EUCRISA 2% Ointment 60GM, a pharmaceutical product. The contract has an ultimate completion date of February 21, 2024 and is structured as a Firm Fixed Price Delivery Order. No set-aside designation was used for this...
- This federal contract award, with ID SPE2DB20D3101|SPE2DB22FJ8V5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,192.65 firm fixed-price delivery order is for the supply of EUCRISA 2% ointment, a topical medication, to support military healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,201.67, is for the delivery of EUCRISA 2% ointment 60GM. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,078.09 firm fixed-price delivery order contract is for the provision of 4566629016 EUCRISA 2% OINTMENT 100GM, with a completion date of December 6, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, with an ID of SPE2DB20D3104|SPE2DB23FV5B6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,602.96 delivery order is for the pharmaceutical product EUCRISA 2% Ointment 60GM and has a completion date of February 7, 2023. The contract is a Firm Fixed Price, Delivery Order type and was awarded without a set-aside designation, indicating open competition....
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FU3S2Delivery Order
This federal contract award, with an ID of SPE2DB20D3505|SPE2DB23FU3S2, is for the delivery of EUCRISA 2% ointment in 60 gram containers. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price of $4,132.87 and an ultimate completion date of July 10, 2023. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which is valued at $999,999,999 and runs through November 2026. The IDC covers a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order does not have a set-aside designation, indicating open competition. The contract award demonstrates Amerisourcebergen's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 7/7/23 |